Alerts will be sent to your verified email
Verify Email
GODAVARI
|
Godavari Drugs
|
Accretion Pharma.
|
Lasa Supergenerics
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
14.02 % | 72.47 % | -8.32 % |
|
5yr average Equity Multiplier
|
3.68 | 5.06 | 1.44 |
|
5yr Average Asset Turnover Ratio
|
1.31 | 1.24 | 0.77 |
|
5yr Avg Net Profit Margin
|
2.93 % | 11.51 % | -8.22 % |
|
Price to Book
|
1.68 | 0.0 | 0.84 |
|
P/E
|
16.62 | 0.0 | 0.0 |
|
5yr Avg Cash Conversion Cycle
|
98.79 Days | 108.78 Days | 11.27 Days |
|
Inventory Days
|
44.55 Days | 156.95 Days | 46.83 Days |
|
Days Receivable
|
136.67 Days | 62.93 Days | 10.61 Days |
|
Days Payable
|
108.22 Days | 111.1 Days | 83.41 Days |
|
5yr Average Interest Coverage Ratio
|
2.53 | 5.99 | -18.91 |
|
5yr Avg ROCE
|
20.29 % | 55.84 % | 1.03 % |
|
5yr Avg Operating Profit Margin
|
7.21 % | 22.25 % | 9.99 % |
|
5 yr average Debt to Equity
|
1.32 | 2.52 | 0.2 |
|
5yr CAGR Net Profit
|
22.65 % | 117.34 % | n/a |
|
5yr Average Return on Assets
|
3.86 % | 14.33 % | -5.59 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
52.63 % | n/a | 53.65 % |
|
Share Pledged by Promoters
|
0.25 % | n/a | 20.66 % |
|
Change in Promoter Holding (3 Yrs)
|
-3.73 % | n/a | 9.87 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | n/a | 0.0 |
|
Godavari Drugs
|
Accretion Pharma.
|
Lasa Supergenerics
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
-
|